Cystitis may present as a nonthreatening condition but can be a significant economic burden. According to an estimate the treatment of cystitis leads to a mean direct cost of 236 pounds per episode. Aetiology and pathogen specific therapies are much more cost effective than broad spectrum therapies used for symptomatic treatment. Hyaluronan therapy given long term cuts down the cost of multiple pretreatments as it prevents recurrence of a Urinary tract infection.
Cystitis cost-effectiveness of therapy
Appendicitis cost-effectiveness of therapy
Pyelonephritis cost-effectiveness of therapy
Cystitis Other Diagnostic Tests
Prostatitis classification
Cystitis future or investigational therapies
Cystitis classification
Urethral cancer classification